Steatotic liver disease (SLD) displays a dynamic and complex disease phenotype.
Consequently, the metabolic dysfunction-associated steatotic liver disease …

Thyroid hormones (triiodothyronine and thyroxine) are pivotal for metabolic balance in the
liver and entire body. Dysregulation of the hypothalamus–pituitary–thyroid axis can …

Abstract Background and Aims Thyroid axis is currently under investigation as a therapeutic
target in metabolic dysfunction‐associated steatotic liver disease (MASLD). Thyroid function …

The central mechanism involved in the pathogenesis of MAFLD is insulin resistance with
hyperinsulinemia, which stimulates triglyceride synthesis and accumulation in the liver. On …

Metabolic dysfunction-associated steatotic liver disease (MASLD) originates from a
homeostatic imbalance in hepatic lipid metabolism. Increased fat deposition in the liver of …

The medical term nonalcoholic fatty liver disease (NAFLD) was coined in 1986 for a
condition that has since become the most prevalent liver disorder worldwide. In the last 3 …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is an important public
health problem owing to its high prevalence and associated morbidity and mortality …

Objective Metabolic-associated fatty liver disease (MAFLD) represents one of the most
prevalent chronic liver conditions worldwide, but its precise pathogenesis remains unclear …

Metabolic dysfunction-associated steatotic liver disease (MASLD) and polycystic ovary
syndrome (PCOS) are prevalent conditions that have been correlated with infertility through …

The introduction of the term “Metabolic Steatotic Liver Disease”(MASLD) underscores the
critical role of metabolic dysfunction in the development and progression of chronic liver …